CERVICAL ADENOCARCINOMA

This study tests whether adding the drug triapine to standard radiation and chemotherapy (cisplatin) helps women with advanced cervical or vaginal cancer live longer. About 450 women with newly diagnosed, bulky stage IB2 to IVA cervical cancer or stage II-IVA vaginal cancer will …

This phase 2 trial tests a combination of two immunotherapy drugs (nivolumab and ipilimumab) in over 800 people with more than 50 types of rare cancers. The goal is to see if this treatment can shrink tumors by helping the immune system attack cancer cells. The study is for patie…

This study tested a drug called nivolumab in 26 women with cervical cancer that had come back or spread despite other treatments. Nivolumab helps the immune system attack cancer cells. The goal was to see if the drug could shrink tumors and how safe it was. While not a cure, it o…

This study looks at whether yoga therapy can improve physical and emotional well-being in people with cervical cancer who are getting chemotherapy and radiation. About 40 patients with stage IB2 to IIIB cervical cancer will take part. They will do yoga sessions that include exerc…

This study is for people with a certain type of cervical cancer (adenocarcinoma) that has spread locally. Researchers want to see how well the cancer responds to standard chemoradiation, and then use imaging and tissue samples to decide if additional surgery, more radiation, or s…